NordicRWE was recently awarded a major public research grant from the Research Council of Norway: during the next three years we will turn the unique Nordic health data into new products and services that will accelerate the drug development process.

The RWE ACCELERATE project will target two highly relevant and interesting RWE areas:

(i) constructing oncology external control arms and

(ii) advanced pharmacoepidemiology and analytics for drug signal detection in large registries.